Sphingolipid players in the leukemia arena

Clara Ricci, Francesco Onida, Riccardo Ghidoni

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Sphingolipids function as bioactive mediators of different cellular processes, mostly proliferation, survival, differentiation and apoptosis, besides being structural components of cellular membranes. Involvement of sphingolipid metabolism in cancerogenesis was demonstrated in solid tumors as well as in hematological malignancies. Herein, we describe the main biological and clinical aspects of leukemias and summarize data regarding sphingolipids as mediators of apoptosis triggered in response to anti-leukemic agents and synthetic analogs as inducers of cell death as well. We also report the contribution of molecules that modulate sphingolipid metabolism to development of encouraging strategies for leukemia treatment. Finally we address how deregulation of sphingolipid metabolism is associated to occurrence of therapy resistance both in vitro and in vivo. Sphingolipids can be considered promising therapeutic tools alone or in combination with other compounds, as well as valid targets in the attempt to eradicate leukemia and overcome drug resistance.

Original languageEnglish
Pages (from-to)2121-2132
Number of pages12
JournalBBA - Biomembranes
Volume1758
Issue number12
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Sphingolipids
Leukemia
Metabolism
Apoptosis
Deregulation
Cell death
Hematologic Neoplasms
Helper-Inducer T-Lymphocytes
Drug Resistance
Tumors
Cell Death
Membranes
Molecules
Therapeutics
Pharmaceutical Preparations
Neoplasms

Keywords

  • Apoptosis
  • Ceramide
  • Chemotherapeutics
  • Leukemia
  • Resistance
  • Sphingolipids

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology

Cite this

Sphingolipid players in the leukemia arena. / Ricci, Clara; Onida, Francesco; Ghidoni, Riccardo.

In: BBA - Biomembranes, Vol. 1758, No. 12, 12.2006, p. 2121-2132.

Research output: Contribution to journalArticle

Ricci, Clara ; Onida, Francesco ; Ghidoni, Riccardo. / Sphingolipid players in the leukemia arena. In: BBA - Biomembranes. 2006 ; Vol. 1758, No. 12. pp. 2121-2132.
@article{d2c419d093a14df2b64560783b43958b,
title = "Sphingolipid players in the leukemia arena",
abstract = "Sphingolipids function as bioactive mediators of different cellular processes, mostly proliferation, survival, differentiation and apoptosis, besides being structural components of cellular membranes. Involvement of sphingolipid metabolism in cancerogenesis was demonstrated in solid tumors as well as in hematological malignancies. Herein, we describe the main biological and clinical aspects of leukemias and summarize data regarding sphingolipids as mediators of apoptosis triggered in response to anti-leukemic agents and synthetic analogs as inducers of cell death as well. We also report the contribution of molecules that modulate sphingolipid metabolism to development of encouraging strategies for leukemia treatment. Finally we address how deregulation of sphingolipid metabolism is associated to occurrence of therapy resistance both in vitro and in vivo. Sphingolipids can be considered promising therapeutic tools alone or in combination with other compounds, as well as valid targets in the attempt to eradicate leukemia and overcome drug resistance.",
keywords = "Apoptosis, Ceramide, Chemotherapeutics, Leukemia, Resistance, Sphingolipids",
author = "Clara Ricci and Francesco Onida and Riccardo Ghidoni",
year = "2006",
month = "12",
doi = "10.1016/j.bbamem.2006.06.016",
language = "English",
volume = "1758",
pages = "2121--2132",
journal = "Biochimica et Biophysica Acta - Biomembranes",
issn = "0005-2736",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Sphingolipid players in the leukemia arena

AU - Ricci, Clara

AU - Onida, Francesco

AU - Ghidoni, Riccardo

PY - 2006/12

Y1 - 2006/12

N2 - Sphingolipids function as bioactive mediators of different cellular processes, mostly proliferation, survival, differentiation and apoptosis, besides being structural components of cellular membranes. Involvement of sphingolipid metabolism in cancerogenesis was demonstrated in solid tumors as well as in hematological malignancies. Herein, we describe the main biological and clinical aspects of leukemias and summarize data regarding sphingolipids as mediators of apoptosis triggered in response to anti-leukemic agents and synthetic analogs as inducers of cell death as well. We also report the contribution of molecules that modulate sphingolipid metabolism to development of encouraging strategies for leukemia treatment. Finally we address how deregulation of sphingolipid metabolism is associated to occurrence of therapy resistance both in vitro and in vivo. Sphingolipids can be considered promising therapeutic tools alone or in combination with other compounds, as well as valid targets in the attempt to eradicate leukemia and overcome drug resistance.

AB - Sphingolipids function as bioactive mediators of different cellular processes, mostly proliferation, survival, differentiation and apoptosis, besides being structural components of cellular membranes. Involvement of sphingolipid metabolism in cancerogenesis was demonstrated in solid tumors as well as in hematological malignancies. Herein, we describe the main biological and clinical aspects of leukemias and summarize data regarding sphingolipids as mediators of apoptosis triggered in response to anti-leukemic agents and synthetic analogs as inducers of cell death as well. We also report the contribution of molecules that modulate sphingolipid metabolism to development of encouraging strategies for leukemia treatment. Finally we address how deregulation of sphingolipid metabolism is associated to occurrence of therapy resistance both in vitro and in vivo. Sphingolipids can be considered promising therapeutic tools alone or in combination with other compounds, as well as valid targets in the attempt to eradicate leukemia and overcome drug resistance.

KW - Apoptosis

KW - Ceramide

KW - Chemotherapeutics

KW - Leukemia

KW - Resistance

KW - Sphingolipids

UR - http://www.scopus.com/inward/record.url?scp=33845284855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845284855&partnerID=8YFLogxK

U2 - 10.1016/j.bbamem.2006.06.016

DO - 10.1016/j.bbamem.2006.06.016

M3 - Article

VL - 1758

SP - 2121

EP - 2132

JO - Biochimica et Biophysica Acta - Biomembranes

JF - Biochimica et Biophysica Acta - Biomembranes

SN - 0005-2736

IS - 12

ER -